Cargando…
Intra-amniotic sildenafil treatment improves lung blood flow and pulmonary hypertension in congenital diaphragmatic hernia rats
Pulmonary hypertension associated with congenital diaphragmatic hernia (CDH) is a critical factor in determining prognosis. We propose that intra-amniotic sildenafil administration is an effective prenatal therapy for CDH-induced pulmonary hypertension. To assess the efficacy of this treatment, we a...
Autores principales: | Yoshida, Shiho, Kreger, Alexander M., Gittes, George K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399963/ https://www.ncbi.nlm.nih.gov/pubmed/37545896 http://dx.doi.org/10.3389/fbioe.2023.1195623 |
Ejemplares similares
-
Intra-amniotic Sildenafil Treatment Modulates Vascular Smooth Muscle Cell Phenotype in the Nitrofen Model of Congenital Diaphragmatic Hernia
por: Okolo, Frances C., et al.
Publicado: (2018) -
Use of sildenafil in late postoperative period of congenital diaphragmatic hernia
por: Falcão, Mário Cícero, et al.
Publicado: (2021) -
Echocardiographic Assessment of Pulmonary Hypertension in Neonates with Congenital Diaphragmatic Hernia Using Pulmonary Artery Flow Characteristics
por: Kipfmueller, Florian, et al.
Publicado: (2022) -
PBPK-based dose finding for sildenafil in pregnant women for antenatal treatment of congenital diaphragmatic hernia
por: Macente, Julia, et al.
Publicado: (2023) -
Identification of protein biomarkers associated with congenital diaphragmatic hernia in human amniotic fluid
por: Bhutada, Sumit, et al.
Publicado: (2023)